Literature DB >> 10203251

Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease.

D Middleton1, H Mawhinney, M D Curran, J A Edwardson, R Perry, I McKeith, C Morris, P G Ince, D Neill.   

Abstract

The frequency of various allele types of the class I Major Histocompatibility Complex (MHC) genes HLA-A and HLA-B were compared between pathologically confirmed groups of late and early-onset Alzheimer's disease (AD) and a control group. DNA was extracted from frozen brain tissue and the highly polymorphic second and third exons of the HLA-A and HLA-B genes were independently PCR amplified using specific primers. Individual allele types were identified using sequence-specific oligonucleotide probes. The results showed that the main frequency differences occurred between the late-onset AD and the control group however none of these reached statistical significance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203251     DOI: 10.1016/s0304-3940(99)00045-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Inflammatory changes parallel the early stages of Alzheimer disease.

Authors:  A Parachikova; M G Agadjanyan; D H Cribbs; M Blurton-Jones; V Perreau; J Rogers; T G Beach; C W Cotman
Journal:  Neurobiol Aging       Date:  2006-10-18       Impact factor: 4.673

2.  HLA-A2 Alleles Mediate Alzheimer's Disease by Altering Hippocampal Volume.

Authors:  Zi-Xuan Wang; Hui-Fu Wang; Lin Tan; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-03-15       Impact factor: 5.590

3.  Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity?

Authors:  Donald J Lehmann; Martin C N M Barnardo; Susan Fuggle; Isabel Quiroga; Andrew Sutherland; Donald R Warden; Lin Barnetson; Roger Horton; Stephan Beck; A David Smith
Journal:  J Neuroinflammation       Date:  2006-12-18       Impact factor: 8.322

4.  Alzheimer's disease and HLA-A2: linking neurodegenerative to immune processes through an in silico approach.

Authors:  Ricardo A Cifuentes; Juan Murillo-Rojas
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

5.  Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.

Authors:  Natasha Z R Steele; Jessie S Carr; Luke W Bonham; Ethan G Geier; Vincent Damotte; Zachary A Miller; Rahul S Desikan; Kevin L Boehme; Shubhabrata Mukherjee; Paul K Crane; John S K Kauwe; Joel H Kramer; Bruce L Miller; Giovanni Coppola; Jill A Hollenbach; Yadong Huang; Jennifer S Yokoyama
Journal:  PLoS Med       Date:  2017-03-28       Impact factor: 11.069

6.  Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach.

Authors:  Negar Sadat Soleimani Zakeri; Saeid Pashazadeh; Habib MotieGhader
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.